Neurofibromatosis type 1 syndrome associated with gastrointestinal stromal tumor

by O B Abukhaidar, D A Filonenko, P P Arkhiri, A A Meshcheriakov, S N Nered, I S Stilidi
Published 2015-06-01

Ribociclib for the treatment of hormone-positive HER2-negative breast cancer

by I. P. Ganshina, D. A. Filonenko, O. O. Gordeeva, E. V. Lubennikova, I. V. Kolyadina, A. A. Mescheryakov
Published 2019-06-01

The use of regorafenib in patients with disseminated gastrointestinal stromal tumours. A review of the literature. A clinical case

by D. A. Filonenko, S. V. Petukhova, E. I. Khatkova, K. A. Vorontsova, E. I. Chichikov, B. M. Medvedeva, L. G. Zhukova
Published 2018-07-01

Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case

by I V Kolyadina, I P Ganshina, L G Zhukova, A G Abdullaev, Yu Yu Andreeva, T Yu Danzanova, G T Sinyukova, D V Komov, N A Kozlov, D A Filonenko, O O Gordeeva, E V Lubennikova
Published 2017-12-01

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer

by O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Ganshina, G. V. Vyshinskaya, M. A. Kazantseva, M. V. Sukhova, O. E. Ryabishina, E. V. Lubennikova, D. A. Filonenko, E. I. Chichikov, I. N. Polushkina, E. I. Borisova, A. N. Lud, A. A. Meshcheryakov
Published 2020-11-01